First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative


Robert McCann, Director of Business Development


First Harvest Financial, a leading educational firm in the legal medical cannabis space, created a web-based resource where legal cannabis startups can interact with corporate executives, serial entrepreneurs and technology accelerators. First Harvest Financial brings together visionary entrepreneurs and medical marijuana advocates looking to strategically enter and capitalize on growing and creating therapeutic cannabis based solutions. Their vision is to improve the quality of life for patients who are dependent on medical cannabis therapies.

Cannavoices, Inc., a premier legal medical cannabis digital media company, launched “Cannavoices,” an unprecedented digital video that set out to investigate this perplexing and highly controversial topic and share their findings in a documentary. Their initiative aims to be the largest and most dynamic collection of legal medical cannabis stories ever assembled.

Cannavoices, Inc. announced earlier this month its early stages of an expansion into the legal medical cannabis media space. They have chosen to partner with First Harvest Financial due to their unprecedented ability to enhance knowledge and understanding about the history and culture of cannabis.

First Harvest Financial is comprised of a talented leadership team that has extensive experience in leading organizations to high-growth within industries such as marketing, finance and technology. Together the firm leaders have over 75 years of experience and nearly 50 industry partners and networks, as well as over 200 social media networks where anyone can be part of the conversation about innovative therapies that are being developed.

First Harvest Financial provides the unique opportunity for like-minded strategic partners to come together and work toward achieving market dominance. They specialize in providing mentorship, guidance and funding.

“First Harvest is a private equity firm that invests in ancillary medical cannabis related companies. We’re primarily made up of over 20 investment advisors that have collectively raised, managed, and advised in excess of 475 million dollars,” said Robert McCann, Director of Business Development of First Harvest Financial. “But what’s really unique about the First Harvest family is most of the team has been familiar with each other for the last 20 years. We all have some type of health story whether it’s a family member or loved one that could’ve had improved health if medical cannabis were fully legalized.”

First Harvest Financial believes that our society will continue to voice the necessary shift in cannabis prohibition laws since the need for holistic therapies hits close to home for so many families.

“There’s a potential to create great value and wealth in this space, but that’s not what drives the First Harvest team. What really drives the First Harvest team is compassion. We see an opportunity to re-purpose our skill sets in a manner that, beyond capitalism, could actually improve the quality of life for millions of patients,” said McCann.

Most doctors know little or nothing about medical cannabis. However, this is changing in the United States in part because the public is demanding it and also because new scientific research concludes the benefits of medical marijuana.

“We have barely even scratched the surface because it’s been so hard to do any research,” said Dr. Gregory L. Smith, M.D., M.P.H. “These new companies that are funding research and funding growth so they can do their own research are vital to the next phase of medical marijuana.”

To learn more about First Harvest Financial including the complete description of the First Harvest Financial mission, please visit firstharvestfinancial.com/

For more information, please contact First Harvest Financial at 1-888-217-5840.

About First Harvest Financial

First Harvest Financial, Inc. works directly with those professionals looking to strategically enter and capitalize on growing and creating therapeutic, cannabis-based solutions in today’s marketplace. The firm provides a platform for legal cannabis startups to interact with corporate executives, serial entrepreneurs, and technology accelerators. For more information, please visit: http://www.firstharvestfinancial.com/







Discovery Health Partners Announces Webinar on Mass Tort Identification and Recovery Solution for Health Payers

ITASCA, IL (PRWEB) February 12, 2015

Discovery Health Partners, a division of LaunchPoint, is offering a webinar on “Best Practices in Mass Tort Identification and Recovery Strategies” on February 24 at 2 p.m. EST. The registration link is available here. Elizabeth A. Longo, General Counsel for Discovery Health Partners, will discuss emerging processes and technologies that automate and streamline the mass tort recovery efforts of payers and can result in millions of dollars recovered. In addition, attendees will learn how to:

    Identify members who have received medical care and a settlement as a result of an allegedly defective drug or medical device.
    Understand the basic processes for obtaining mass tort recoveries.
    Distinguish the identification and recovery process required for traditional subrogation/TPL cases vs. mass tort cases.
    Recognize recent mass tort cases and their impact on recoveries.

“Our webinar will address strategies for giving payers a more proactive and systematic approach to mass tort identification and recoveries through a combination of technology, analytics, and legal expertise,” said Longo. “Many recovery opportunities associated with mass tort litigation are often overlooked, but hold huge implications for payers. When you consider some plans could have hundreds or thousands of members impacted by a single mass tort (such as by a defective pelvic mesh or hip implant), the financial impact could be staggering.”

Discovery Health Partners recently added a Mass Tort solution to Discovery Subrogation, which is part of the Discovery Payment Integrity Suite of software and solutions. The Mass Tort solution leverages a proprietary cloud-based healthcare analytics platform for data integration, identification, case management, and reporting.

About the presenter

Longo is an established cost containment attorney with more than 20 years of recovery and litigation experience. She has a proven record of achieving optimal subrogation recoveries for Discovery Health Partners’ clients across all lines of business. Longo has handled thousands of subrogation cases involving motor vehicle accidents, mass torts, slip and falls, product liability, medical malpractice, and general liability with significant positive outcomes. In addition, she has recovered millions of dollars annually for plans she has represented. Longo has developed and implemented extensive subrogation training and mentoring programs for Discovery Health Partners team members, as well as policies and procedures related to compliance, Medicare and Medicaid requirements, HIPAA Privacy and Security Rules, and ICD-10 transition.

About Discovery Health Partners

Discovery Health Partners offers the Discovery Payment Integrity SuiteTM of payment integrity software and solutions to help health plans and other healthcare organizations optimize revenue, avoid costs, and improve recoveries. A combination of deep healthcare experience and powerful technology solutions helps clients drive improved payment integrity and generate measurable results. Discovery Health Partners is a division of LaunchPoint, which was recently named the 100th fastest-growing company on the 2014 Inc. 500 list. LaunchPoint operates businesses that provide cloud-based solutions, software, and services for healthcare organizations. Learn more at http://www.discoveryhealthpartners.com







NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice

Rochelle, Virginia (PRWEB) October 20, 2014

Earle Martin, Chief Executive Officer of NDA Partners LLC, announced today that Ellen Teplitzky, an experienced attorney specializing in business matters and legal support for the pharmaceutical industry, has joined the firm as Director of Legal Services and manager of its legal services practice. NDA Partners provides legal services, including research, expert reports and expert witness and testimony, to top law firms and their clients in cases involving complex issues such as product liability, patent infringement, generic competition, and regulatory agency process. The firm’s expert consultants are some of the most respected and accomplished pharmaceutical scientists and industry executives in the world, including former senior executives from the US Food and Drug Administration (FDA), EU regulatory agencies, and major pharmaceutical companies.

“Ms. Teplitzky brings a level of knowledge and experience to our legal practice that will greatly benefit the law firms we work with and their clients,” said Mr. Martin. “These cases are very complex and demanding, and require a deep understanding of the process and issues. Ms. Teplitzky’s support for our legal engagements will further our goal of providing the high quality services and support that our clients expect.”

Ms. Teplitzky has prior experience as Vice President of Legal Affairs at Aptiv Solutions, a contract research organization (CRO); legal counsel at Clinical Transfer Technology Group, a law firm specializing in legal services for pharmaceutical and biotechnology clients; Director of Contracts & Legal Affairs at PRA International, an international CRO; and Corporate Counsel Consultant with Lexis-Nexis. She was awarded her LLM degree from King’s College (London, England) with Merit, JD degree from Emory University School of Law (Atlanta, GA), and received a BA in History at Emory College.

About NDA Partners

NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.







More Legal Press Releases